Another phase 2 randomized trial in patients with treatment naïve metastatic PDA also failed to demonstrate an improvement in PFS in patients that received the combination of gemcitabine with vismodegib, another SHh inhibitor [30]. Here, SHH is linked to Patent ductus arteriosus.